Get started
Author

Chara Stavraka

Observed names: C Stavraka, C. Stavraka, CHARA STAVRAKA, Stavraka, C., Stavraka, Chara
Observed institutions: AstraZeneca (United Kingdom), Guy's Hospital, St Thomas' Hospital, Royal Marsden NHS Foundation Trust, Imperial College Healthcare NHS Trust, Queen Mary University of London, Royal Free London NHS Foundation Trust, King's College London, Guy's and St Thomas' NHS Foundation Trust, Aristotle University of Thessaloniki, Norfolk and Norwich University Hospital, Norfolk and Norwich University Hospitals NHS Foundation Trust, Cancer Research UK, Hammersmith Hospital, Charing Cross Hospital, National Institute for Health and Care Research, Ovarian Cancer Action, Papageorgiou General Hospital, Velindre Cancer Centre, King's College Hospital, Barts Cancer Institute, University College London, Imperial College London, Cardiff University, Wellcome Trust
ORCID: 0000-0001-7623-299X
Observed ORCID: 0000-0001-7623-299X
OpenAlex ID: A5010813520
The La-Related Proteins, a Family with Connections to Cancer
2015 · Chara Stavraka, Sarah Blagden · Biomolecules · 133
PDF
Combined hepatocellular cholangiocarcinoma (cHCC-CC): an update of genetics, molecular biology, and therapeutic interventions
2018 · Chara Stavraka, Hannah Rush, et al. · Journal of Hepatocellular Carcinoma · 125
PDF
Folate receptor alpha in ovarian cancer tissue and patient serum is associated with disease burden and treatment outcomes
2022 · Heather J. Bax, Jitesh Chauhan, et al. · British Journal of Cancer · 100
PDF
A study of symptoms described by ovarian cancer survivors
2011 · Chara Stavraka, Amy Ford, et al. · Gynecologic Oncology · 95
Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer
2023 · Joris van de Haar, Xuhui Ma, et al. · Nature Medicine · 93
PDF
Basophils from Cancer Patients Respond to Immune Stimuli and Predict Clinical Outcome
2020 · Heather J. Bax, Jitesh Chauhan, et al. · Cells · 52
PDF
Risk of Ovarian Cancer Relapse Score
2015 · Ivana Rizzuto, Chara Stavraka, et al. · International Journal of Gynecological Cancer · 52
PDF
Clinical and Translational Significance of Basophils in Patients with Cancer
2022 · Jitesh Chauhan, Chara Stavraka, et al. · Cells · 50
PDF
Anti-cancer pro-inflammatory effects of an IgE antibody targeting the melanoma-associated antigen chondroitin sulfate proteoglycan 4
2023 · Jitesh Chauhan, Melanie Grandits, et al. · Nature Communications · 49
PDF
Safety and anti-tumour activity of the IgE antibody MOv18 in patients with advanced solid tumours expressing folate receptor-alpha: a phase I trial
2023 · James Spicer, Bristi Basu, et al. · Nature Communications · 48
PDF
The role of gut microbiome in modulating response to immune checkpoint inhibitor therapy in cancer
2021 · Abdul Rafeh Naqash, Alba J. Kihn-Alarcón, et al. · Annals of Translational Medicine · 48
PDF
Biliary Tract Cancers: Molecular Heterogeneity and New Treatment Options
2020 · Nicola Personeni, Ana Lleo, et al. · Cancers · 45
PDF
First-in-Human Study of CH5132799, an Oral Class I PI3K Inhibitor, Studying Toxicity, Pharmacokinetics, and Pharmacodynamics, in Patients with Metastatic Cancer
2014 · Sarah Blagden, Aurelius Olmin, et al. · Clinical Cancer Research · 45
Insights from IgE Immune Surveillance in Allergy and Cancer for Anti-Tumour IgE Treatments
2021 · Alex J. McCraw, Jitesh Chauhan, et al. · Cancers · 44
PDF
Sexual activity and functioning in ovarian cancer survivors: an internet-based evaluation
2014 · T. G. Hopkins, C. Stavraka, et al. · Climacteric · 43
IgE Antibodies against Cancer: Efficacy and Safety
2020 · Jitesh Chauhan, Alex McCraw, et al. · Antibodies · 39
PDF
An Inflammation Based Score Can Optimize the Selection of Patients with Advanced Cancer Considered for Early Phase Clinical Trials
2014 · David J. Pinato, Chara Stavraka, et al. · PLoS ONE · 35
PDF
Non-Small Cell Lung Cancer (NSCLC) in Young Adults, Age < 50, Is Associated with Late Stage at Presentation and a Very Poor Prognosis in Patients That Do Not Have a Targeted Therapy Option: A Real-World Study
2022 · Daniel Johnathan Hughes, Matthaios Kapiris, et al. · Cancers · 28
PDF
How frequently are bedside glucose levels measured in hospital inpatients on glucocorticoid treatment?
2014 · Vishal Narwani, Leyla Swafe, et al. · Clinical Medicine · 28
Clinical implementation of pre-treatment DPYD genotyping in capecitabine-treated metastatic breast cancer patients
2019 · Chara Stavraka, Athanasios Pouptsis, et al. · Breast Cancer Research and Treatment · 27
PDF
A Study to Evaluate the Cause of Bone Demineralization in Gynecological Cancer Survivors
2013 · Chara Stavraka, Kate Maclaran, et al. · The Oncologist · 27
PDF
Hyperinflammatory repolarisation of ovarian cancer patient macrophages by anti-tumour IgE antibody, MOv18, restricts an immunosuppressive macrophage:Treg cell interaction
2025 · Gabriel Osborn, Jacobo López-Abente, et al. · Nature Communications · 26
PDF
IgE Activates Monocytes from Cancer Patients to Acquire a Pro-Inflammatory Phenotype
2020 · Mano Nakamura, Elmira Amiri Souri, et al. · Cancers · 26
PDF
Surgical and Systemic Treatment of Hereditary Breast Cancer: A Mini-Review With a Focus on BRCA1 and BRCA2 Mutations
2020 · Athanasios Pouptsis, Leyla Swafe, et al. · Frontiers in Oncology · 26
PDF
Coagulopathy in COVID-19 infection: a case of acute upper limb ischemia
2020 · Nikiforos Galanis, Chara Stavraka, et al. · Journal of Surgical Case Reports · 26
PDF
Works count: 79
Citation count: 1,580
H-index: 25
I10-index: 35
Year
Topic
Type